| Nitric-oxide-lowering effect of terlipressin in decompensated cirrhosis: comparison to the molecular adsorbent recirculating system and correlation with clinical status. | |
| | |
MedLine Citation:
|
PMID: 15618842 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Systemic vasodilatation and arterial hypotension, refractory to adrenergic vasopressors, portend a poor prognosis in patients with decompensated cirrhosis. The production of large amounts of nitric oxide, consequent to endotoxin-induced tumour necrosis factor (TNF)-alpha-mediated upregulation of inducible nitric oxide synthase (iNOS), has been suggested to be central to this phenomenon. Terlipressin has recently been shown in an animal model of cirrhosis to suppress endotoxin-induced TNF-alpha-mediated upregulation of iNOS, thereby preventing overproduction of nitric oxide and restoring normal vascular tone. We present the first evidence that this effect of terlipressin may also occur clinically, in a patient with Child-Pugh class C cirrhosis, endotoxaemia, a raised circulating TNF-alpha concentration, and marked systemic vasodilatation with refractory arterial hypotension. Beneficial effects of terlipressin on circulating nitrate and nitrite concentrations, haemodynamic status, plasma renin levels and indocyanine green clearance were comparable to those of the molecular adsorbent recirculating system (MARS). Our findings suggest that terlipressin may be the vasopressor agent of choice in patients with decompensated cirrhosis and provide a rationale for combination terlipressin and MARS therapy when the therapeutic response to either treatment alone is suboptimal. |
| | |
Authors:
|
Jelica Kurtovic; Martin Boyle; David Bihari; Stephen M Riordan |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European journal of gastroenterology & hepatology Volume: 16 ISSN: 0954-691X ISO Abbreviation: Eur J Gastroenterol Hepatol Publication Date: 2004 Nov |
Date Detail:
|
Created Date: 2004-12-24 Completed Date: 2005-03-17 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9000874 Medline TA: Eur J Gastroenterol Hepatol Country: England |
Other Details:
|
Languages: eng Pagination: 1335-8 Citation Subset: IM |
Affiliation:
|
Gastrointestinal and Liver Unit, The Prince of Wales Hospital and University of New South Wales, Sydney, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Endotoxemia / blood, complications, drug therapy Humans Hypotension / complications, drug therapy Liver Cirrhosis / blood, complications, drug therapy* Liver, Artificial Lypressin / analogs & derivatives*, therapeutic use* Male Nitric Oxide / blood* Sorption Detoxification / methods* Tumor Necrosis Factor-alpha / analysis Vasoconstrictor Agents / therapeutic use* Vasodilation / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Tumor Necrosis Factor-alpha; 0/Vasoconstrictor Agents; 10102-43-9/Nitric Oxide; 14636-12-5/terlipressin; 50-57-7/Lypressin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Palpable epigastric liver as a physical sign of cirrhosis: a prospective study.
Next Document: Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilic...